- Waldencast Reports Q1 2024 Financial Results
- Waldencast plc Announces First Quarter Fiscal 2024 Earnings Release Date, Conference Call and Webcast
- Waldencast Announces Participation in CreatorIQ Connect Europe
- Waldencast Reports Fiscal Year 2023 Financial Results
- Waldencast Regains Compliance with Nasdaq Filing Requirements
- Waldencast Reports First Half 2023 Results
- Obagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream
- Waldencast Receives Positive Nasdaq Listing Determination
- Waldencast Announces New “Creative Council” of Industry Pioneers and Disruptors
- Dr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc.
More ▼
Key statistics
On Tuesday, Waldencast PLC (WALD:NAQ) closed at 4.18, 12.52% above the 52 week low of 3.72 set on May 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.14 |
---|---|
High | 4.25 |
Low | 3.88 |
Bid | 4.00 |
Offer | 5.35 |
Previous close | 4.18 |
Average volume | 128.03k |
---|---|
Shares outstanding | 122.19m |
Free float | 52.90m |
P/E (TTM) | -- |
Market cap | 510.75m USD |
EPS (TTM) | -0.9871 USD |
Data delayed at least 15 minutes, as of May 28 2024 21:00 BST.
More ▼